APA (7th ed.) Citation

J, Y., GD, L., JH, K., SN, L., H, C., E, H., . . . M, K. (2020). Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome. Annals of laboratory medicine, 40(2), 148. https://doi.org/10.3343/alm.2020.40.2.148

Chicago Style (17th ed.) Citation

J, Yoo, Lee GD, Kim JH, Lee SN, Chae H, Han E, Kim Y, and Kim M. "Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome." Annals of Laboratory Medicine 40, no. 2 (2020): 148. https://doi.org/10.3343/alm.2020.40.2.148.

MLA (9th ed.) Citation

J, Yoo, et al. "Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome." Annals of Laboratory Medicine, vol. 40, no. 2, 2020, p. 148, https://doi.org/10.3343/alm.2020.40.2.148.